These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1978545)

  • 1. Beta blockers and the primary prevention of nonfatal myocardial infarction in patients with high blood pressure.
    Psaty BM; Koepsell TD; Wagner EH; LoGerfo JP; Inui TS
    Am J Cardiol; 1990 Nov; 66(16):12G-14G. PubMed ID: 1978545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure.
    Psaty BM; Koepsell TD; LoGerfo JP; Wagner EH; Inui TS
    JAMA; 1989 Apr; 261(14):2087-94. PubMed ID: 2564445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of myocardial infarction associated with antihypertensive drug therapies.
    Psaty BM; Heckbert SR; Koepsell TD; Siscovick DS; Raghunathan TE; Weiss NS; Rosendaal FR; Lemaitre RN; Smith NL; Wahl PW
    JAMA; 1995 Aug 23-30; 274(8):620-5. PubMed ID: 7637142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers.
    Psaty BM; Koepsell TD; Wagner EH; LoGerfo JP; Inui TS
    JAMA; 1990 Mar 23-30; 263(12):1653-7. PubMed ID: 1968518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-blockers for protection against hypertensive target-organ damage].
    Takahashi F
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():583-6. PubMed ID: 15171440
    [No Abstract]   [Full Text] [Related]  

  • 7. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers: primary and secondary prevention.
    Cruickshank JM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S55-69. PubMed ID: 1284145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin and beta-blocker therapy and the initial presentation of coronary heart disease.
    Go AS; Iribarren C; Chandra M; Lathon PV; Fortmann SP; Quertermous T; Hlatky MA;
    Ann Intern Med; 2006 Feb; 144(4):229-38. PubMed ID: 16490908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.
    Bangalore S; Sawhney S; Messerli FH
    J Am Coll Cardiol; 2008 Oct; 52(18):1482-9. PubMed ID: 19017516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly.
    Teichert M; de Smet PA; Hofman A; Witteman JC; Stricker BH
    Drug Saf; 2007; 30(6):541-9. PubMed ID: 17536880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of β-adrenergic receptor blockers in managing hypertension.
    Poirier L; Lacourcière Y
    Can J Cardiol; 2012 May; 28(3):334-40. PubMed ID: 22595449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of blood pressure and risk of myocardial infarction among treated hypertensive patients.
    McCloskey LW; Psaty BM; Koepsell TD; Aagaard GN
    Arch Intern Med; 1992 Mar; 152(3):513-20. PubMed ID: 1347678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
    Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE
    Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F; Ragot S; Julien J; Herpin D
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can treatment of hypertension prevent myocardial infarction? New controlled clinical trials are proposed].
    Kjeldsen SE; Syvertsen JO; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1993 Feb; 113(6):737-40. PubMed ID: 8096658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.